AVEO Oncology
AVEO
$15.00
Share price
0.00%
Change (1 day)
170.76%
Change (1 year)
Categories
Market capitalization of AVEO Oncology (AVEO)
Market cap: $0.52 Billion
As of May 2024 AVEO Oncology has a market cap of $0.52 Billion. This makes AVEO Oncology the world's 5990th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of AVEO Oncology from 2010 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.52 B | 0% |
| 2023 | $0.52 B | 0.33% |
| 2022 | $0.51 B | 222.37% |
| 2021 | $0.16 B | -3.02% |
| 2020 | $0.16 B | 65.57% |
| 2019 | $0.10 B | -50.39% |
| 2018 | $0.20 B | -38.7% |
| 2017 | $0.33 B | 705.83% |
| 2016 | $40.96 M | -44.12% |
| 2015 | $73.3 M | 66.87% |
| 2014 | $43.93 M | -53.66% |
| 2013 | $94.81 M | -73.1% |
| 2012 | $0.35 B | -52.57% |
| 2011 | $0.74 B | 42.75% |
| 2010 | $0.52 B |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $740.30 B | 141,872.09% | 🇺🇸 USA |
 Amgen AMGN | $167.56 B | 32,033.85% | 🇺🇸 USA |
 Biogen BIIB | $33.37 B | 6,301.34% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $107.51 B | 20,518.62% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $89.31 B | 17,027.43% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $0.21 B | -57.82% | 🇺🇸 USA |